Prolonged survival after surgical resection of cerebral metastasis from melanoma with multisystemic metastasis already present
a case report and literature review
Keywords:
Melanoma, Neoplasm metastasis, Glasgow coma scaleAbstract
CONTEXT: Malignant melanoma is the third most common cause of cerebral metastases after breast and lung cancer. Despite advances in therapeutic options, the prognosis for patients with cerebral metastases from melanoma remains poor, with a median survival time of six months after diagnosis. CASE REPORT: A 65-year-old woman was diagnosed with a malignant melanoma on the third toe of her left foot. The tumorous spot was excised surgically. However, the melanoma reappeared after one year and skin bi- opsy confirmed recurrence of malignant melanoma. Investigations showed metastasis to the left pelvic region, left lobe of the liver and right lobe of the lung. The patient then received chemotherapy. Subsequently, the pa- tient was brought to the emergency department with an altered level of consciousness (Glasgow coma scale: 9) and hemiplegia on the right side of her body. Computed tomography scans of the brain revealed hemorrhagic lesions in the parieto-occipital lobes of the brain. Urgent surgical evacuation was done to remove the lesion, following which the patient showed improvement in her score on the Glasgow coma scale and a concomitant decrease in weakness. She was discharged from hospital with full consciousness. The patient died of acute renal failure 14 months after the brain surgery and approximately 4 years after the initial presentation of the case. CONCLUSION: This case outcome is rare and shows the effectiveness of surgery to treat cerebral metasta- sis from malignant melanoma in a situation with multisystem metastasis already present.
Downloads
References
National Cancer Institute. Melanoma Treatment (PDQ®) - Health Professionals Version; 2015. Available from: https://www.cancer.gov/types/skin/hp/melanoma-treatment-pdq. Accessed in 2017 (Apr 10).
Bastiaannet E, Beukema JC, Hoekstra HJ. Radiation therapy following lymph node dissection in melanoma patients: treatment, outcome and complications. Cancer Treat Rev. 2005;31(1):18-26.
Bajetta E, Del Vecchio M, Bernard-Marty C, et al. Metastatic melanoma: chemotherapy. Semin Oncol. 2002;29(5):427-45.
McQuade JL, Posada LP, Lecagoonporn S, et al. A phase I study of TPI 287 in combination with temozolomide for patients with metastatic melanoma. Melanoma Res. 2016;26(6):604-8.
Bright R, Coventry BJ, Eardley-Harris N, Briggs N. Clinical Response Rates From Interleukin-2 Therapy for Metastatic Melanoma Over 30 Years’ Experience: A Meta-Analysis of 3312 Patients. J Immunother. 2017;40(1):21-30.
Fernandez E, Maira G, Puca A, Vignati A. Multiple intracranial metastases of malignant melanoma with long-term survival. Case report. J Neurosurg. 1984;60(3):621-4.